Midi Health vs Alloy vs Evernow: Telehealth Menopause Clinic Comparison 2026
The womens hormone telehealth market exploded in 2023-2025 alongside growing awareness of perimenopause and menopause undertreatment. Three clinics now capture most patient research traffic: Midi Health (comprehensive menopause care with broad specialty), Alloy (tiered pricing with strong consumer experience), and Evernow (flat-fee comprehensive care). Each takes a different approach to a similar clinical problem. The differences affect both monthly cost and breadth of treatment available.
- › Midi Health: $199/mo. Most comprehensive menopause care with multidisciplinary team. Best for complex cases.
- › Alloy: $49-$199/mo tiered. Most flexible with lowest entry point. Best for price-conscious or symptom-focused patients.
- › Evernow: $199/mo. Personalized boutique experience with single-provider continuity. Best for customized care.
- › Annual cost: Alloy $588-$2,388 vs Midi $2,388 vs Evernow $2,388.
- › All three prescribe FDA-approved bioidentical hormones, which may be insurance-covered separately ($5-$30 monthly copay).
- › Subscription fees are out-of-pocket but eligible for HSA/FSA.
Pricing Structure
Midi Health: $199/month subscription model. Includes initial bloodwork, video consultation with a menopause-trained clinician, ongoing prescription management, follow-up visits, and unlimited messaging with the care team. Most comprehensive structure.
Alloy: Tiered pricing from $49/month (medication only, no consultation included beyond initial) to $199/month (premium tier with regular check-ins). The flexibility allows patients to choose the service intensity that matches their needs. Alloy also offers a la carte hormone medications without subscription.
Evernow: $199/month subscription. Includes ongoing care with menopause-specialized clinicians, prescription management, lab orders when needed, and patient messaging. Similar comprehensiveness to Midi.
Annual cost: Alloy $588-$2,388 depending on tier, Midi and Evernow both $2,388 at the premium subscription level. Alloy at the $49 tier is the most affordable entry point if you do not need extensive consultation time.
Hormone Options Available
All three clinics prescribe FDA-approved bioidentical hormones (estradiol patches, transdermal estradiol gel, oral progesterone) which are the recommended first-line treatments per NAMS guidelines.
Midi Health: Extensive menu including estradiol patches, gels, and rings; oral progesterone; testosterone for women (low-dose); compounded options when commercial products are insufficient; and select peptide protocols where legally available. Most comprehensive prescribing breadth.
Alloy: Comprehensive menu including all major FDA-approved bioidentical hormones, compounded BHRT options, vaginal estrogen for genitourinary symptoms, and non-hormonal options for women who cannot use hormones (Veozah/fezolinetant). Strong on the genitourinary symptom treatment side.
Evernow: Similar comprehensive menu to Midi and Alloy. Strong focus on personalized regimens including testosterone for low libido.
Differences in prescribing breadth are real but most patients with typical menopause symptoms find adequate options at any of the three.
Prescriber and Care Team Model
Midi Health uses NAMS-certified menopause practitioners (typically nurse practitioners with specialty training) plus a multidisciplinary care team. Continuity with the same provider is encouraged.
Alloy uses physicians (MDs) including OB-GYNs with menopause specialty experience plus nurse practitioners. Patient gets matched with a specific clinician who manages the case longitudinally.
Evernow uses physicians and menopause-specialized nurse practitioners. Personalized treatment plans with strong emphasis on continuity.
All three have menopause-trained prescribers. The provider quality is comparable; the differences are in care model structure (multidisciplinary team vs single-provider continuity).
Patient Experience
Midi Health emphasizes a clinical experience with regular video appointments and comprehensive symptom tracking through their app. Most clinician-led of the three.
Alloy emphasizes a consumer-friendly experience with cleaner branding and a more app-driven interface. Initial consultation is more streamlined; ongoing care depends on tier chosen.
Evernow emphasizes a personalized boutique-style experience with extensive intake assessment and customized regimens. Slower onboarding but more depth per patient.
For patients who want efficient access with minimal friction, Alloy at the entry tier is best. For patients who want extensive clinician time, Midi or Evernow are better.
Insurance and HSA/FSA
None of the three accept insurance for the subscription itself. However, FDA-approved hormone prescriptions filled through commercial pharmacies (Walgreens, CVS, mail-order) may be insurance-covered at $5-$30 monthly copay.
This is an important point: Midi, Alloy, and Evernow subscription fees ($49-$199/month) are out-of-pocket, but the medications they prescribe are often insurance-covered separately. Many patients pay $199/month for the service plus $10/month for insurance-covered estradiol patches, rather than the full retail cost of medications.
HSA and FSA funds can typically be used for the subscription fees.
Geographic Coverage
All three operate telehealth nationally. State-by-state coverage varies based on telehealth licensing.
Midi Health operates in 40+ states. Alloy operates in 30+ states. Evernow operates in 40+ states.
Some states (California, New York) have additional telehealth requirements that may add to onboarding time. Confirm your state with each clinic before subscribing.
Who Should Choose Midi Health
Midi Health is the right choice for patients who:
- Want the most comprehensive menopause care with multidisciplinary team - Have multiple menopausal symptoms requiring coordinated treatment - Prefer regular clinician engagement and structured care plans - Are willing to pay $199/month for comprehensive service - Want to add testosterone or peptide protocols beyond standard BHRT
Midi is the strongest comprehensive menopause clinic in 2026 for patients seeking specialized, team-based care.
Who Should Choose Alloy
Alloy is the right choice for patients who:
- Want tiered pricing flexibility (from $49/month medication-only to $199/month premium) - Have clear symptom focus and know the medications they need - Prefer a streamlined consumer experience with strong app interface - Want flexibility to scale service intensity up or down - Are price-conscious and want the lowest legitimate telehealth entry point
Alloy at $49/month is the most affordable legitimate menopause telehealth option in 2026.
Who Should Choose Evernow
Evernow is the right choice for patients who:
- Want a personalized boutique-style experience with extensive intake - Have unique symptom presentations requiring customized regimens - Value continuity with a single dedicated provider - Are comfortable with slower onboarding for deeper care - Want strong focus on libido, mood, and quality-of-life issues beyond core menopausal symptoms
Evernow is the strongest personalized-care option in 2026 for patients seeking depth over breadth.
Frequently Asked Questions
Which is the best menopause telehealth clinic in 2026? +
No single best — depends on your needs. Midi Health for comprehensive multidisciplinary care, Alloy for tiered pricing flexibility (including the most affordable legitimate $49/month entry point), Evernow for personalized boutique experience with single-provider continuity. All three use menopause-specialized prescribers and FDA-approved hormones.
How much does menopause telehealth cost in 2026? +
Midi Health $199/month all-inclusive. Alloy $49-$199/month depending on tier. Evernow $199/month all-inclusive. Annual cost: Alloy $588-$2,388 vs Midi/Evernow $2,388. Medications prescribed are often insurance-covered separately at $5-$30 monthly copay.
Is Alloy legitimate at $49/month? +
Yes. Alloy at the $49 tier provides medication management with reduced ongoing consultation. Initial assessment and FDA-approved hormone prescription are included. The lower price reflects reduced ongoing service intensity, not reduced safety or quality. Many patients with stable menopause symptoms find this tier adequate after the first 3-6 months.
Will my insurance cover the prescription? +
Often yes for FDA-approved bioidentical hormones (estradiol patches, oral progesterone) when filled at commercial pharmacies. Many patients pay $199/month for Midi or Evernow service plus $10/month for insurance-covered estradiol patches separately. This is the lowest-cost combination for comprehensive care.
Can I get testosterone for women through these clinics? +
Yes through all three for appropriate clinical indications. Testosterone for women is typically prescribed at very low doses (1/10 to 1/20 of male doses) for low libido or hypoactive sexual desire disorder. Midi and Evernow have the most established protocols; Alloy offers it as well.
Can I switch between Midi, Alloy, and Evernow? +
Yes. Records are portable. Many patients try one clinic for 3-6 months and switch if needed. There is no long-term contract with any of the three.
Are these clinics safer than my regular OB-GYN? +
Not necessarily safer, but typically more menopause-specialized than a general OB-GYN who treats menopause as a small fraction of their practice. The telehealth menopause clinics employ NAMS-certified menopause practitioners with deeper experience in menopause-specific prescribing. For patients whose general OB-GYN is comfortable with comprehensive menopause management, that path is fine. For patients whose OB-GYN dismisses symptoms or only offers limited options, menopause-specialized telehealth is typically more responsive.
Bottom Line
For most women researching menopause telehealth options in 2026, Alloy at $49-$99/month is the most affordable legitimate entry point with FDA-approved hormone prescribing. Midi and Evernow at $199/month offer more comprehensive care models suited to complex cases or patients who want regular clinician engagement. All three are legitimate options employing menopause-specialized prescribers and FDA-approved bioidentical hormones. The medications they prescribe are often separately insurance-covered, making the effective total cost lower than the subscription fee alone suggests.
Sources
- NAMS Position Statement on Hormone Therapy. Menopause, 2022. (Clinical guidelines on BHRT)
- Provider websites: joinmidi.com, myalloy.com, evernow.com (Q1 2026 pricing). (Current published pricing)
- Manson JE, et al. WHI long-term mortality analysis. JAMA, 2017. (Long-term BHRT safety)